Skip to content
Home/Companies/HealthTech/Perspecta

Perspecta

HealthTech·United States·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Perspecta?

Perspecta is currently owned by Quilvest Capital Partners through QCP Buyout Fund III (2025 vintage), since 2025.

Hand-verified · updated 2026-09-29

Quilvest Capital Partners
Investor
Quilvest Capital Partners
QCP Buyout Fund III · 2025 · Buyout

Key facts

HQUnited States
SectorHealthTech
StatusActive

More from QCP Buyout Fund III

Other portfolio companies in the same fund.

Intarcia Therapeutics
Exited 2023
BiotechUS
to i2O Therapeutics
Acuiti Labs
Active
TMTFrance· 2025
Cabaia
Cabaia
Active
ConsumerFrance· 2025
Ermitage
Ermitage
Active
ConsumerFrance· 2025
Fullers Foods
Fullers Foods
Active
ConsumerFrance· 2025
FundamentalCo
Active
Business ServicesUS· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue